-
Study aim
-
Evaluation of the effectiveness of integrated drug therapy and respiratory training with incentive spirometer on mortality and recovery rates of adult patients admitted to hospital with Covid 19.
-
Design
-
A clinical trial with the control group, with parallel groups, three-way blind, randomized, phase 3 on 160 patients. Randomization will be performed using the rand function of Excel software.
-
Settings and conduct
-
Participants are among 19 patients admitted to the non-intensive care unit of Imam Hussein Hospital in Tehran. Patients will be divided into intervention and control groups. Both study groups receive the same drug and non-drug treatments according to the latest published version of the national protocol. The case group will perform breathing exercises according to the study protocol. By assigning a dedicated code to participants, data collectors, treatment teams, patients, and analysts are blinded to group assignments.
-
Participants/Inclusion and exclusion criteria
-
Patients with definite Covid19, greater equal 18 years old with peripheral oxygen levels less than 94% who do not require intensive care, no pregnancy, and no history of chronic lung or heart disease.
-
Intervention groups
-
Eligible patients will be divided into two groups of 80, control and intervention. Both groups receive the same drug treatment according to the declared protocol. In addition, the intervention group was asked to perform breathing exercises with an encouraging spirometer on a daily basis.
-
Main outcome variables
-
-Clinical recovery rate
-Severity Dyspnea based on Modified Borg 0-10 scale (MBS)
-Blood pressure; Heart rate; Respiratory rate; Symptoms of respiratory distress in the form of intercostal and sternal retraction and use of respiratory sub-muscles; O2 sat (pulse oximetry) in two modes with/without (oxygen therapy)